TY - STD TI - Tran V-T, Harrington M, Montori VM, Barnes C, Wicks P, Ravaud P. Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform. BMC Med [Internet]. 2014 [cited 2018 Sep 4];12(1):109. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24989988 UR - http://www.ncbi.nlm.nih.gov/pubmed/24989988 ID - ref1 ER - TY - STD TI - May C, Montori VM, Mair FS. We need minimally disruptive medicine. BMJ [Internet] 2009 [cited 2019 Jan 21];339(aug11 2):b2803–b2803. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19671932. UR - http://www.ncbi.nlm.nih.gov/pubmed/19671932 ID - ref2 ER - TY - STD TI - May CR, Eton DT, Boehmer K, Gallacher K, Hunt K, Macdonald S, et al. Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness [Internet]. Vol. 14. 2014 [cited 2018 Sep 4]. Available from: http://www.biomedcentral.com/1472-6963/14/281 UR - http://www.biomedcentral.com/1472-6963/14/281 ID - ref3 ER - TY - STD TI - Tran V-T, Montori VM, Eton DT, Baruch D, Falissard B, Ravaud P. Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions. BMC Med [Internet]. 2012 [cited 2018 Sep 4];10(1):68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22762722 UR - http://www.ncbi.nlm.nih.gov/pubmed/22762722 ID - ref4 ER - TY - STD TI - Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J, MSCOI Study Group the MS, et al. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler [Internet]. 2017 [cited 2019 Jan 16];23(8):1123–1136. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28273775 UR - http://www.ncbi.nlm.nih.gov/pubmed/28273775 ID - ref5 ER - TY - STD TI - Gold R, Toumi M, Meesen B, Fogarty E. The payer’s perspective: what is the burden of MS and how should the patient’s perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment? Mult Scler [Internet]. 2016 [cited 2019 Jan 16];22(2 Suppl):60–70. Available from: http://journals.sagepub.com/doi/10.1177/1352458516650743 UR - http://journals.sagepub.com/doi/10.1177/1352458516650743 ID - ref6 ER - TY - STD TI - Kobelt G, Eriksson J, Phillips G, Berg J. The burden of multiple sclerosis 2015: Methods of data collection, assessment and analysis of costs, quality of life and symptoms. Mult Scler J [Internet]. 2017 [cited 2019 Jan 16];23(2_suppl):4–16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28643592 UR - http://www.ncbi.nlm.nih.gov/pubmed/28643592 ID - ref7 ER - TY - STD TI - Wicks P, Massagli M, Kulkarni A, Dastani H. Use of an online community to develop patient-reported outcome instruments: the multiple sclerosis treatment adherence questionnaire (MS-TAQ). J Med Internet Res [Internet]. 2011 [cited 2019 Jan 17];13(1):e12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21266318 UR - http://www.ncbi.nlm.nih.gov/pubmed/21266318 ID - ref8 ER - TY - STD TI - Agency EM. EMEA HRQL Guidance. 2005 [cited 2019 Feb 15];(July). Available from: http://www.emea.eu.int UR - http://www.emea.eu.int ID - ref9 ER - TY - STD TI - U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes [Internet]. 2006 [cited 2019 Feb 15];4(1):79. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17034633 UR - http://www.ncbi.nlm.nih.gov/pubmed/17034633 ID - ref10 ER - TY - STD TI - Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol [Internet]. 2011 [cited 2019 Jan 24];69(2):292–302. Available from: http://doi.wiley.com/10.1002/ana.22366 UR - http://doi.wiley.com/10.1002/ana.22366 ID - ref11 ER - TY - STD TI - Acquadro C, Conway K, Hareendran A, Aaronson N, European Regulatory Issues and Quality of Life Assessment (ERIQA) Group. Literature Review of Methods to Translate Health-Related Quality of Life Questionnaires for Use in Multinational Clinical Trials. Value Heal [Internet]. 2008 [cited 2019 Jan 10];11(3):509–521. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18179659 UR - http://www.ncbi.nlm.nih.gov/pubmed/18179659 ID - ref12 ER - TY - STD TI - Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology [Internet]. 1983 [cited 2019 Feb 6];33(11):1444–1452. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6685237 UR - http://www.ncbi.nlm.nih.gov/pubmed/6685237 ID - ref13 ER - TY - STD TI - Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain [Internet]. 1999 [cited 2019 Feb 6];122 ( Pt 5):871–882. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10355672 UR - http://www.ncbi.nlm.nih.gov/pubmed/10355672 ID - ref14 ER - TY - STD TI - Benedict RH, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R, et al. Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis. Mult Scler J [Internet]. 2017 [cited 2019 Feb 6];23(5):721–733. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28206827 UR - http://www.ncbi.nlm.nih.gov/pubmed/28206827 ID - ref15 ER - TY - STD TI - Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler [Internet]. 2012 [cited 2019 Feb 6];18(6):891–898. Available from: http://journals.sagepub.com/doi/10.1177/1352458511431076 UR - http://journals.sagepub.com/doi/10.1177/1352458511431076 ID - ref16 ER - TY - STD TI - Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res [Internet]. 1995 [cited 2019 Feb 6];4(3):187–206. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7613530 UR - http://www.ncbi.nlm.nih.gov/pubmed/7613530 ID - ref17 ER - TY - STD TI - Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol [Internet]. 1989 [cited 2019 Feb 6];46(10):1121–1123. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2803071 UR - http://www.ncbi.nlm.nih.gov/pubmed/2803071 ID - ref18 ER - TY - STD TI - Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med [Internet]. 1991 [cited 2019 Feb 6];32(6):705–714. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2035047 UR - http://www.ncbi.nlm.nih.gov/pubmed/2035047 ID - ref19 ER - TY - STD TI - BECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry [Internet]. 1961 [cited 2019 Feb 6];4:561–571. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13688369 UR - http://www.ncbi.nlm.nih.gov/pubmed/13688369 ID - ref20 ER - TY - STD TI - Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand [Internet]. 1983 [cited 2019 Feb 6];67(6):361–370. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6880820 UR - http://www.ncbi.nlm.nih.gov/pubmed/6880820 ID - ref21 ER - TY - STD TI - Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care [Internet]. 1986 [cited 2019 Feb 6];24(1):67–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3945130 UR - http://www.ncbi.nlm.nih.gov/pubmed/3945130 ID - ref22 ER - TY - STD TI - Gorgas JG, Cardiel NL, Zamorano JC. Estadística Básica para Estudiantes de Ciencias [Internet]. 2011. 258 p. Available from: http://webs.ucm.es/info/Astrof/users/jaz/ESTADISTICA/libro_GCZ2009.pdf UR - http://webs.ucm.es/info/Astrof/users/jaz/ESTADISTICA/libro_GCZ2009.pdf ID - ref23 ER - TY - STD TI - Grupe DW, Nitschke JB. Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. Nat Rev Neurosci [Internet]. 2013 [cited 2019 Jan 17];14(7):488–501. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23783199 UR - http://www.ncbi.nlm.nih.gov/pubmed/23783199 ID - ref24 ER - TY - STD TI - Streiner DL. A checklist for evaluating the usefulness of rating scales. Can J Psychiatr [Internet]. 1993 [cited 2019 Feb 9];38(2):140–148. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8467441 UR - http://www.ncbi.nlm.nih.gov/pubmed/8467441 ID - ref25 ER - TY - STD TI - Manjaly Z-M, Harrison NA, Critchley HD, Do CT, Stefanics G, Wenderoth N, et al. Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis. J Neurol Neurosurg Psychiatry [Internet] 2019 [cited 2019 Feb 17];jnnp-2018-320050. Available from: http://jnnp.bmj.com/lookup/doi/10.1136/jnnp-2018-320050. UR - https://doi.org/http://jnnp.bmj.com/lookup/doi/10.1136/jnnp-2018-320050 ID - ref26 ER - TY - STD TI - Mateen FJ, Manalo NC, Grundy SJ, Houghton MA, Hotan GC, Erickson H, et al. Light therapy for multiple sclerosis-associated fatigue. Medicine (Baltimore) [Internet]. 2017 [cited 2019 Feb 17];96(36):e8037. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28885372 UR - http://www.ncbi.nlm.nih.gov/pubmed/28885372 ID - ref27 ER - TY - STD TI - Krupp L. Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease. Mult Scler [Internet]. 2006 [cited 2019 Feb 17];12(4):367–368. Available from: http://journals.sagepub.com/doi/10.1191/135248506ms1373ed UR - http://journals.sagepub.com/doi/10.1191/135248506ms1373ed ID - ref28 ER - TY - STD TI - Ysrraelit MC, Fiol MP, Gaitán MI, Correale J. Quality of life assessment in multiple sclerosis: different perception between patients and neurologists. Front Neurol [Internet]. 2018 [cited 2019 Jan 23];8:729. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29375468 UR - http://www.ncbi.nlm.nih.gov/pubmed/29375468 ID - ref29 ER - TY - STD TI - Thach A V., Brown CM, Herrera V, Sasane R, Barner JC, Ford KC, et al. Associations Between Treatment Satisfaction, Medication Beliefs, and Adherence to Disease-Modifying Therapies in Patients with Multiple Sclerosis. Int J MS Care [Internet]. 2018 [cited 2019 Jan 22];20(6):251–259. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30568562 UR - http://www.ncbi.nlm.nih.gov/pubmed/30568562 ID - ref30 ER - TY - STD TI - Higuera L, Carlin CS, Anderson S. Adherence to Disease-Modifying Therapies for Multiple Sclerosis. J Manag Care Spec Pharm [Internet]. 2016 [cited 2019 Jan 22];22(12):1394–1401. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27882830 UR - http://www.ncbi.nlm.nih.gov/pubmed/27882830 ID - ref31 ER - TY - STD TI - Cohen BA, Coyle PK, Leist T, Oleen-Burkey MA, Schwartz M, Zwibel H. Therapy optimization in multiple sclerosis: a cohort study of therapy adherence and risk of relapse. Mult Scler Relat Disord [Internet]. 2015 [cited 2019 Jan 22];4(1):75–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25787057 UR - http://www.ncbi.nlm.nih.gov/pubmed/25787057 ID - ref32 ER - TY - STD TI - Evans C, Marrie RA, Zhu F, Leung S, Lu X, Kingwell E, et al. Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations. Pharmacoepidemiol Drug Saf [Internet]. 2017 [cited 2019 Jan 22];26(6):702–711. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28370875 UR - http://www.ncbi.nlm.nih.gov/pubmed/28370875 ID - ref33 ER - TY - STD TI - Eton DT, Yost KJ, Lai J, Ridgeway JL, Egginton JS, Rosedahl JK, et al. Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden. Qual Life Res [Internet]. 2017 [cited 2019 Jan 21];26(2):489–503. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27566732 UR - http://www.ncbi.nlm.nih.gov/pubmed/27566732 ID - ref34 ER - TY - STD TI - Mohammed MA, Moles RJ, Hilmer SN, Kouladjian O’Donnel L, Chen TF. Development and validation of an instrument for measuring the burden of medicine on functioning and well-being: the medication-related burden quality of life (MRB-QoL) tool. BMJ Open [Internet]. 2018 [cited 2019 Jan 20];8(1):e018880. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29330175 UR - http://www.ncbi.nlm.nih.gov/pubmed/29330175 ID - ref35 ER - TY - STD TI - Sav A, King MA, Whitty JA, Kendall E, McMillan SS, Kelly F, et al. Burden of treatment for chronic illness: a concept analysis and review of the literature. Health Expect [Internet]. 2015 [cited 2019 Jan 19];18(3):312–324. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23363080 UR - http://www.ncbi.nlm.nih.gov/pubmed/23363080 ID - ref36 ER - TY - STD TI - Sav A, Salehi A, Mair FS, McMillan SS. Measuring the burden of treatment for chronic disease: implications of a scoping review of the literature. BMC Med Res Methodol [Internet]. 2017 [cited 2019 Jan 15];17(1):140. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28899342 UR - http://www.ncbi.nlm.nih.gov/pubmed/28899342 ID - ref37 ER - TY - STD TI - Ridgeway JL, Egginton JS, Tiedje K, Linzer M, Boehm D, Poplau S, et al. Factors that lessen the burden of treatment in complex patients with chronic conditions: a qualitative study. Patient Prefer Adherence [Internet]. 2014 [cited 2018 Sep 4];8:339–351. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24672228 UR - http://www.ncbi.nlm.nih.gov/pubmed/24672228 ID - ref38 ER - TY - STD TI - Gallacher KI, May CR, Langhorne P, Mair FS. A conceptual model of treatment burden and patient capacity in stroke. BMC Fam Pract [Internet]. 2018 [cited 2019 Jan 24];19(1):9. Available from: https://bmcfampract.biomedcentral.com/articles/10.1186/s12875-017-0691-4 UR - https://bmcfampract.biomedcentral.com/articles/10.1186/s12875-017-0691-4 ID - ref39 ER - TY - STD TI - Boehmer KR, Kyriacou M, Behnken E, Branda M, Montori VM. Patient capacity for self-care in the medical record of patients with chronic conditions: a mixed-methods retrospective study. BMC Fam Pract [Internet]. 2018 [cited 2019 Feb 24];19(1):164. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30285746 UR - http://www.ncbi.nlm.nih.gov/pubmed/30285746 ID - ref40 ER - TY - STD TI - Heckman BW, Mathew AR, Carpenter MJ. Treatment burden and treatment fatigue as barriers to health chronic disease and health behaviors HHS public access. 2015 [cited 2018 Sep 4];5:31–36. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465180/pdf/nihms673094.pdf UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465180/pdf/nihms673094.pdf ID - ref41 ER - TY - STD TI - Mohammed MA, Moles RJ, Chen TF. Medication-related burden and patients’ lived experience with medicine: a systematic review and metasynthesis of qualitative studies. BMJ Open [Internet]. 2016 [cited 2019 Jan 20];6(2):e010035. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26839015 UR - http://www.ncbi.nlm.nih.gov/pubmed/26839015 ID - ref42 ER - TY - STD TI - Spencer-Bonilla G, Quiñones AR, Montori VM, International Minimally Disruptive Medicine Workgroup. Assessing the Burden of Treatment. J Gen Intern Med [Internet]. 2017 [cited 2018 Sep 4];32(10):1141–1145. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28699060 UR - http://www.ncbi.nlm.nih.gov/pubmed/28699060 ID - ref43 ER - TY - STD TI - Mair FS, May CR. Thinking about the burden of treatment. BMJ [Internet]. 2014 [cited 2019 Jan 21];349(nov10 4):g6680–g6680. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25385748 UR - http://www.ncbi.nlm.nih.gov/pubmed/25385748 ID - ref44 ER -